Terrence D Mccanna, MD | |
2525 County Hwy I, Chippewa Falls, WI 54729 | |
(715) 723-9375 | |
(715) 723-1092 |
Full Name | Terrence D Mccanna |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 33 Years |
Location | 2525 County Hwy I, Chippewa Falls, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285743989 | NPI | - | NPPES |
32120800 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 36571020 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension Our Lady Of Victory Hospital | Stanley, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Chippewa Valley Eye Clinic Chippewa Falls Sc | 0446395800 | 4 |
News Archive
Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability (ID), as well as the most frequent monogenic cause of autism spectrum disorders (ASD). FXS is caused by the absence or incorrect production of the protein FMRP (Fragile X Mental Retardation Protein).
Researchers at the University of Rochester Medical Center have coined a simple formula that predicts how well a certain chemotherapy will work for targeting brain and other nervous system cancers. The formula, which publishes mid-July in Cancer Chemotherapy and Pharmacology, is pegged to two important proteins that compose such hard-to-kill tumors - one of which, ironically, makes them so drug-resistant in the first place.
UnitedHealth Group today announced the final results for its previously announced modified "Dutch Auction" cash tender offers for certain of its notes. The tender offers expired at 12:00 midnight, New York City time, on February 5, 2010. As of the expiration date, UnitedHealth Group received tenders for $474 million aggregate principal amount of its short-term notes and $586 million aggregate principal amount of its intermediate-term notes.
A brain study in infant rats demonstrates that the anti-epilepsy drug phenobarbital stunts neuronal growth, which could prompt new questions about using the first-line drug to treat epilepsy in human newborns.
Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust and long-lived humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in both young and aging mice.
› Verified 9 days ago
Entity Name | Chippewa Valley Eye Clinic Chippewa Falls Sc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487710638 PECOS PAC ID: 0446395800 Enrollment ID: O20100310000179 |
News Archive
Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability (ID), as well as the most frequent monogenic cause of autism spectrum disorders (ASD). FXS is caused by the absence or incorrect production of the protein FMRP (Fragile X Mental Retardation Protein).
Researchers at the University of Rochester Medical Center have coined a simple formula that predicts how well a certain chemotherapy will work for targeting brain and other nervous system cancers. The formula, which publishes mid-July in Cancer Chemotherapy and Pharmacology, is pegged to two important proteins that compose such hard-to-kill tumors - one of which, ironically, makes them so drug-resistant in the first place.
UnitedHealth Group today announced the final results for its previously announced modified "Dutch Auction" cash tender offers for certain of its notes. The tender offers expired at 12:00 midnight, New York City time, on February 5, 2010. As of the expiration date, UnitedHealth Group received tenders for $474 million aggregate principal amount of its short-term notes and $586 million aggregate principal amount of its intermediate-term notes.
A brain study in infant rats demonstrates that the anti-epilepsy drug phenobarbital stunts neuronal growth, which could prompt new questions about using the first-line drug to treat epilepsy in human newborns.
Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust and long-lived humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in both young and aging mice.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Terrence D Mccanna, MD 2525 County Hwy I, Chippewa Falls, WI 54729 Ph: (715) 723-9375 | Terrence D Mccanna, MD 2525 County Hwy I, Chippewa Falls, WI 54729 Ph: (715) 723-9375 |
News Archive
Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability (ID), as well as the most frequent monogenic cause of autism spectrum disorders (ASD). FXS is caused by the absence or incorrect production of the protein FMRP (Fragile X Mental Retardation Protein).
Researchers at the University of Rochester Medical Center have coined a simple formula that predicts how well a certain chemotherapy will work for targeting brain and other nervous system cancers. The formula, which publishes mid-July in Cancer Chemotherapy and Pharmacology, is pegged to two important proteins that compose such hard-to-kill tumors - one of which, ironically, makes them so drug-resistant in the first place.
UnitedHealth Group today announced the final results for its previously announced modified "Dutch Auction" cash tender offers for certain of its notes. The tender offers expired at 12:00 midnight, New York City time, on February 5, 2010. As of the expiration date, UnitedHealth Group received tenders for $474 million aggregate principal amount of its short-term notes and $586 million aggregate principal amount of its intermediate-term notes.
A brain study in infant rats demonstrates that the anti-epilepsy drug phenobarbital stunts neuronal growth, which could prompt new questions about using the first-line drug to treat epilepsy in human newborns.
Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust and long-lived humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in both young and aging mice.
› Verified 9 days ago
Peter W Holm, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 2525 County Highway I, Chippewa Falls, WI 54729 Phone: 715-723-9375 Fax: 715-723-1092 | |
Dr. John C Moffitt, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2525 County Hwy I, Chippewa Falls, WI 54729 Phone: 715-723-9375 | |
Jeffrey F Brown, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2525 County Highway I, Chippewa Falls, WI 54729 Phone: 715-723-9375 Fax: 715-723-1092 | |
Dr. Thomas Michael Harvey, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2751 Commercial Blvd Ste 6, Chippewa Falls, WI 54729 Phone: 715-449-8400 Fax: 715-449-8400 | |
Mr. David P Sutton, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2525 County Highway I, Chippewa Falls, WI 54729 Phone: 715-723-9375 Fax: 715-723-1092 |